Seer Inc (SEER) News

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis...

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study

REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Seer Reports First Quarter 2024 Financial Results

REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences...

Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions

New Seer Technology Access Center to open in Bonn, Germany Provides life sciences researchers conducting...

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook

REDWOOD CITY, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences...

Form 4 - Statement of changes in beneficial ownership of securities

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences...

Form 4 - Statement of changes in beneficial ownership of securities